Authors: Mary A. Williamson Mt(ascp) Phd,L. Michael Snyder Md
Various drugs (e.g., NSAIDs, ACE inhibitors, cyclosporine, pentamidine)
Decreased aldosterone production
Pseudohypoaldosteronism
Aldosterone antagonist drugs (e.g., spironolactone, captopril, heparin)
Inhibition of tubular secretion of potassium
Drugs (e.g., spironolactone, triamterene, amiloride)
Hyperkalemic type of distal RTA (e.g., sickle cell disease, obstructive uropathy)
Mineralocorticoid-resistant syndromes
Primary tubular disorders
Hereditary
Acquired (e.g., SLE, amyloidosis, sickle cell nephropathy, obstructive uropathy, renal allograft transplant, chloride shift)
Potassium redistribution
Familial hyperkalemic periodic paralysis (Gamstorp disease, adynamia episodica hereditaria)